| Literature DB >> 34633845 |
Anne-Laure Bidaud1, Patrick Schwarz2,3, Anuradha Chowdhary4, Eric Dannaoui1,5.
Abstract
Terbinafine is used as the first-line therapy for dermatophytosis, but the incidence of terbinafine resistance is increasing. A combination of terbinafine with itraconazole was tested using the checkerboard method based on the EUCAST methodology for antifungal susceptibility testing against 9 terbinafine-susceptible and 7 terbinafine-resistant clinical isolates of Trichophyton spp. from India. Synergistic interactions were observed for 4/9 of the susceptible isolates, with fractional inhibitory concentration index (FICI) values of 0.3125 to 0.5, and for 4/7 of the resistant isolates, with FICI values of 0.032 to 0.3125.Entities:
Keywords: EUCAST; Trichophyton; antifungal combination; dermatophytes; itraconazole; terbinafine
Mesh:
Substances:
Year: 2021 PMID: 34633845 PMCID: PMC8765265 DOI: 10.1128/AAC.01449-21
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.938